CareLit Fachartikel

Lungenkarzinom

N.N. · DMW - Deutsche Medizinische Wochenschrift · 2014 · Heft 11 · S. 545-556

Dokument
982423
CareLit-ID
Jahr
2014
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
DMW - Deutsche Medizinische Wochenschrift
Autor:innen
N.N.
Ausgabe
Heft 11 / 2014
Jahrgang 139
Seiten
545-556
Erschienen: 2014-03-01 00:00:00
ISSN
0012-0472
DOI
10.1055/s-0033-1349593

Zusammenfassung

Abstract Lung cancer is histologically classified as small cell (SCLC) and non-small cell lung cancer (NSCLC). NSCLC cancer is subclassified as squamous cell carcinoma, adenocarcinoma and large cell carcinoma. Activating EGFR mutations and EML4-ALK translocation are relevant in NSCLC, especially in non-squamous tumours. This pathological classification, as well as patient condition (performance status, functional limitations and comorbidities) and stage of disease, guides the management of these patients. Surgery, radiotherapy and systemic therapy using platinum-based chemotherapy doublets are the main stay of t…

Schlagworte

Stadium Lungenfunktion Komorbidität aktivierende EGFR-Mutation EML4-ALK-Translokation Multimodale Therapie Stage lung function comorbidity activating EGFR mutation EML4-ALK translocation multimodality treatment DMW - Deutsche Medizinische Wochenschrift